SEARCH

SEARCH BY CITATION

References

  • 1
    Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010; 23: 689712.
  • 2
    Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779795.
  • 3
    Myhre HA, Haug Dorenberg D, Kristiansen KI, et al. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 2011; 92: 217223.
  • 4
    Couzi L, Helou S, Bachelet T, et al. High incidence of anti-cytomegalovirus drug resistance among D+R— kidney transplant recipients receiving preemptive therapy. Am J Transplant 2011.
  • 5
    van der Beek MT, Berger SP, Vossen AC, et al. Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: Comparison of treatment failure and antiviral resistance. Transplantation 2010; 89: 320326.